Literature DB >> 23195117

The effect of the extent of lymph node dissection for stage IA non-small-cell lung cancer on patient disease-free survival.

Feng Xu1, LiSha Qi, DongSheng Yue, ChangLi Wang.   

Abstract

BACKGROUND: Systematic LN dissection has been proposed as 1 of the important parts of the standard surgery for NSCLC for decades. However, controversy exists as to whether extensive LN dissection has benefit for early stage NSCLC patients. The aim of the present study was to investigate whether the extent of dissection affects the DFS of stage IA patients. PATIENTS AND METHODS: The stations dissected and the LN obtained during operations from stage IA NSCLC patients were recorded and the patients were grouped according to the number of dissected LN (N), total stations (NS) and mediastinal stations (N2). The DFS curve of patients from each group were generated by the Kaplan-Meier method and compared with the log-rank test. The correlation between the patients' clinical features and N retrieval were also analyzed.
RESULTS: A total of 203 stage IA NSCLC patients were grouped (N ≤ 10, 10 < N ≤ 20, and N > 20; NS ≥ 6 and NS < 6; N2 ≥ 3 and N2 < 3) and analyzed. Right-sided disease, tumor maximal diameter > 2 cm, and more NS or N2 dissected correlated with more retrieval of LN (P = .001, .003, < .001, < .001). The increase of N, NS, and N2 dissected were found to predict improved DFS (P = .001, .019, < .001), but there were no significant survival differences between the N ≤ 20 and N > 20 patients within the NS ≥ 6 subset (P = .140).
CONCLUSION: The dissection of more stations did increase the harvest of LN, which could achieve better survival for a stage IA NSCLC patient. The number of dissected (mediastinal) stations served as a more significant prognostic factor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23195117     DOI: 10.1016/j.cllc.2012.09.002

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  10 in total

1.  Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.

Authors:  Eric M Robinson; Ilkka K Ilonen; Kay See Tan; Andrew J Plodkowski; Matthew Bott; Manjit S Bains; Prasad S Adusumilli; Bernard J Park; Valerie W Rusch; David R Jones; James Huang
Journal:  Ann Thorac Surg       Date:  2019-08-31       Impact factor: 4.330

2.  Topography of the sentinel node according to the affected lobe in lung cancer.

Authors:  J M Galbis-Caravajal; A Lafuente-Sanchis; M Estors-Guerrero; N Martinez-Hernández; C Fuster-Diana; A Cremades; Á Zúñiga
Journal:  Clin Transl Oncol       Date:  2017-01-27       Impact factor: 3.405

Review 3.  State of the art in surgery for early stage NSCLC-does the number of resected lymph nodes matter?

Authors:  Laura Romero Vielva; Manuel Wong Jaen; José A Maestre Alcácer; Mecedes Canela Cardona
Journal:  Transl Lung Cancer Res       Date:  2014-04

4.  Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection.

Authors:  Yang Liu; Jianfei Shen; Liping Liu; Lanlan Shan; Jiaxi He; Qihua He; Long Jiang; Minzhang Guo; Xuewei Chen; Hui Pan; Guilin Peng; Honghui Shi; Limin Ou; Wenhua Liang; Jianxing He
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer.

Authors:  Miaomiao Yang; Hongxin Cao; Xi Guo; Tiehong Zhang; Pingping Hu; Jiajun Du; Qi Liu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 6.  Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Xiongfeng Huang; Jianmin Wang; Qiao Chen; Jielin Jiang
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 7.  Thoracotomy is better than thoracoscopic lobectomy in the lymph node dissection of lung cancer: a systematic review and meta-analysis.

Authors:  Wenxiong Zhang; Yiping Wei; Han Jiang; Jianjun Xu; Dongliang Yu
Journal:  World J Surg Oncol       Date:  2016-11-17       Impact factor: 2.754

8.  The significance of systematic lymph node dissection in surgery for early-stage non-small cell lung cancer patients aged ≤40 years.

Authors:  Zhi-Yi Guo; Jiang-Hao Ren; Yuan-Yuan Xu; Rui-Jun Liu; Hui Tao; Jia Huang; Qiang Tan
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

9.  Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.

Authors:  Chengcheng Fan; Shugeng Gao; Zhouguang Hui; Jun Liang; Jima Lv; Xiaozhen Wang; Jie He; Luhua Wang
Journal:  Radiat Oncol       Date:  2013-12-09       Impact factor: 3.481

10.  Clinical analysis of sixty-four patients with T1aN2M0 stage non-small cell lung cancer who had undergone resection.

Authors:  Jian Xiong; Rui Wang; Yihua Sun; Haiquan Chen
Journal:  Thorac Cancer       Date:  2015-10-06       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.